About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Arbitration Award Issued

November 12, 2018

Click here to read more

Post navigation

Receipt of R&D Tax Incentive

Receipt of R&D Tax Incentive

Related Posts

Phosphagenics Provides Update on TPM Propofol Development Program

November 9, 2017

Ethics Approval to Commence Topical TPM®/Oxycodone Patch Trial

December 8, 2014

2016 Sep 12 Phosphagenics Updates Long Term Incentive Scheme

September 12, 2016

Recent Posts

Media Coverage | Nine News
October 21, 2024
First Patient Dosed in Phase III Insomnia Trial
May 16, 2024
MEDIA | Channel 9 News
March 28, 2024

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.